Published in Eur Radiol on June 18, 2011
PET/CT and MRI in Bladder Cancer. J Cancer Sci Ther (2012) 0.95
Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques. J Magn Reson Imaging (2013) 0.92
Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report. Eur Radiol (2013) 0.86
Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer. Transl Oncol (2015) 0.83
Quantitative apparent diffusion coefficient measurements obtained by 3-Tesla MRI are correlated with biomarkers of bladder cancer proliferative activity. PLoS One (2014) 0.79
Comparison of Coregistration Accuracy of Pelvic Structures Between Sequential and Simultaneous Imaging During Hybrid PET/MRI in Patients with Bladder Cancer. Clin Nucl Med (2015) 0.78
Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI. World J Urol (2012) 0.78
Investigation of Apparent Diffusion Coefficient from Ultra-high b-Values in Parkinson's Disease. Eur Radiol (2015) 0.77
Diffusion-weighted MRI as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer. Br J Radiol (2014) 0.77
Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy. World J Radiol (2014) 0.76
Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion. Eur Radiol (2017) 0.76
Current Staging Procedures in Urinary Bladder Cancer. Diagnostics (Basel) (2013) 0.75
Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation. Can Urol Assoc J (2017) 0.75
The Role of Computerized Tomography in the Assessment of Perivesical Invasion in Bladder Cancer. Pol J Radiol (2016) 0.75
Apparent diffusion coefficient measurement by diffusion weighted magnetic resonance imaging is a useful tool in differentiating renal tumors. BMC Cancer (2015) 0.75
Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study. Eur Radiol (2016) 0.75
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol (2001) 11.35
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol (2006) 8.78
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
Basic principles of diffusion-weighted imaging. Eur J Radiol (2003) 2.93
Cystectomy for bladder cancer: a contemporary series. J Urol (2001) 1.85
Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology (2008) 1.73
Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results. Br J Radiol (2004) 1.69
Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology (1997) 1.62
Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol (2004) 1.56
Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology (2009) 1.53
Muscle-invasive urothelial carcinoma of the bladder. Urology (2007) 1.46
Diffusion imaging of the prostate at 3.0 tesla. Invest Radiol (2006) 1.40
Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol (2009) 1.38
Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. Radiology (2009) 1.28
Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol (2006) 1.21
FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging (2005) 1.20
A second-look TUR in T1 transitional cell carcinoma: why? Eur Urol (2004) 1.13
The value of a second transurethral resection in evaluating patients with bladder tumours. Eur Urol (2003) 1.10
MR staging of bladder carcinoma: correlation with pathologic findings. Radiology (1988) 1.07
Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology (2009) 1.06
Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging. Eur Radiol (2009) 1.06
The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement? Crit Rev Oncol Hematol (2003) 1.02
The usefulness of diffusion-weighted imaging (DWI) for the detection of gastric cancer. Hepatogastroenterology (2007) 1.02
[F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma. Int J Clin Oncol (2008) 0.99
Primary bladder carcinoma: evaluation with MR imaging. Radiology (1987) 0.93
Diffusion-weighted MRI of urinary bladder and prostate cancers. Diagn Interv Radiol (2009) 0.88
Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? AJR Am J Roentgenol (2009) 0.86
Diffusion-weighted magnetic resonance imaging. J Neuroophthalmol (2002) 0.85
PET: a revolution in medical imaging. Radiol Clin North Am (2004) 0.85
Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted magnetic resonance imaging. Int J Urol (2008) 0.82
Superficial bladder cancer: the primacy of grade in the development of invasive disease. J Clin Oncol (1987) 0.80
Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology (2008) 0.80
Urinary bladder MR imaging. Part II. Neoplasm. Radiology (1985) 0.79
Integrative annotation of 21,037 human genes validated by full-length cDNA clones. PLoS Biol (2004) 7.17
A promoter-level mammalian expression atlas. Nature (2014) 6.25
Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res (2008) 3.56
Early infection of scutellum tissue with Agrobacterium allows high-speed transformation of rice. Plant J (2006) 3.09
Erect leaves caused by brassinosteroid deficiency increase biomass production and grain yield in rice. Nat Biotechnol (2005) 2.89
Integral role of Noxa in p53-mediated apoptotic response. Genes Dev (2003) 2.50
Efficacy of moderate hypothermia in patients with severe head injury and intracranial hypertension refractory to mild hypothermia. J Neurosurg (2003) 2.27
Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Eur Urol (2007) 2.15
Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur Urol (2007) 2.11
Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet (2011) 2.10
New three-dimensional head-mounted display system, TMDU-S-3D system, for minimally invasive surgery application: procedures for gasless single-port radical nephrectomy. Int J Urol (2012) 2.08
Abnormal dimercapto-succinic acid scan is a predictive factor of breakthrough urinary tract infection in children with primary vesicoureteral reflux. J Urol (2009) 2.01
The analysis of efficacy for AutoPulse™ system in flying helicopter. Resuscitation (2013) 1.98
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet (2004) 1.91
Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science (2015) 1.91
Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res (2003) 1.90
Genetic manipulation of gibberellin metabolism in transgenic rice. Nat Biotechnol (2003) 1.83
On experiences of i2b2 (Informatics for integrating biology and the bedside) database with Japanese clinical patients' data. Bioinformation (2011) 1.82
High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol (2013) 1.76
Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat Commun (2012) 1.71
Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Eur Urol (2008) 1.71
Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care (2002) 1.70
Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients. Blood (2007) 1.69
An empirical examination of the utility of codon-substitution models in phylogeny reconstruction. Syst Biol (2005) 1.69
Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol (2011) 1.68
Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma. Eur Urol (2008) 1.67
Altered gut flora and environment in patients with severe SIRS. J Trauma (2006) 1.67
Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel. Urology (2011) 1.63
Immortalized neural stem cells transplanted into the injured spinal cord promote recovery of voiding function in the rat. J Urol (2003) 1.61
Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res (2009) 1.61
Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int J Cancer (2011) 1.58
The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity. J Immunol (2003) 1.54
Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia. Blood (2012) 1.54
Evolving arch surgery using integrated antegrade selective cerebral perfusion: impact of axillary artery perfusion. J Thorac Cardiovasc Surg (2008) 1.53
Evolving selective cerebral perfusion for aortic arch replacement: high flow rate with moderate hypothermic circulatory arrest. Ann Thorac Surg (2008) 1.53
Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology (2009) 1.53
Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate. BJU Int (2008) 1.52
Diversity of preferred nucleotide sequences around the translation initiation codon in eukaryote genomes. Nucleic Acids Res (2007) 1.52
Multidisciplinary approach to prevent spinal cord ischemia after thoracic endovascular aneurysm repair for distal descending aorta. Ann Thorac Surg (2010) 1.51
Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL. Urology (2012) 1.48
Predictive model for estimating risk of crush syndrome: a data mining approach. J Trauma (2007) 1.48
Oxidative stress causes heart failure with impaired mitochondrial respiration. J Biol Chem (2006) 1.48
Surgical practices for urological tumors: a nation-wide survey in Japan in 2005. Int J Urol (2009) 1.48
Effectiveness of the new 'Mobile AED Map' to find and retrieve an AED: A randomised controlled trial. Resuscitation (2010) 1.47
Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU Int (2015) 1.46